Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report On the basis of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback